Furthermore, Meridian Market Consultants (MMC) Study identifies that, in 25% to 70% of patients ocular graft-versus-host disease is responsible for non-relapse morbidity and mortality.

As per the report, growing prevalence of gastroesophageal reflux disease (GERD) and poor management of GERD are prime factors driving growth of Barrette’s esophagus treatment market.

As per the report, increasing prevalence of anemia and haemochromatosis is attributed to growth of global iron metabolism disorder drugs market.

As per the report, analgesics are the one and the most important part of post-operative pain management that includes various drug classes and drug forms.

As per the report, growing prevalence of gastric adenocarcinoma and availability of new treatment options are the main factors driving growth of gastric cancer treatment market.